Home

David L Brinkley

CIK 1302445 · Head of Business Dev. · last filed 2019-07-18

David L Brinkley is a Head of Business Dev. who has filed 47 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for PETX, was dated Jul 18, 2019. Across all open-market trades the lifetime net is −$11.5M, making them a net seller over the disclosed history. 46 SEC filings were submitted jointly with Innoviva, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$11.47M

Filer Profile

Reported Address
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Related Filers
Innoviva, Inc. — 46 joint filings, latest 2013-05-31
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARATANA THERAPEUTICS, INC. (PETX) Delisted Director 0 — — $0 7 2019-07-18
Innoviva, Inc. (THRX) Delisted Head of Business Dev. 48,749 $4.06 $197.9K -$11.47M 40 2013-05-31

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-07-18 ARATANA THERAPEUTICS, INC. (PETX) Delisted Disp (D) −18,000 $0 EDGAR
2019-06-07 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2018-07-30 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2017-06-23 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2016-06-28 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2015-06-19 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) — $0 EDGAR
2014-03-28 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) — $0 EDGAR
2013-05-31 Innoviva, Inc. (THRX) Delisted Sell (S) −3,808 -$133.3K EDGAR
2013-05-22 Innoviva, Inc. (THRX) Delisted Tax (F) −2,443 -$90.4K EDGAR
2013-05-15 Innoviva, Inc. (THRX) Delisted Mixed — -$102.1K EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.